Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1130 result(s) found, displaying 701 to 725

  • AusPAR: Carglumic acid

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Carglumic acid

  • AusPAR: Etanercept

    Australian public assessment report (AusPar)
    Australian public assessment report for Etanercept

  • AusPAR: Secukinumab

    Australian public assessment report (AusPar)
    AusPAR: Secukinumab

  • AusPAR: Rituximab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rituximab

  • AusPAR: Botulinum toxin type A

    Australian public assessment report (AusPar)
    Australian public assessment report for Botulinum toxin type A

  • AusPAR: Triptorelin acetate

    Australian public assessment report (AusPar)
    Australian public assessment report for Triptorelin acetate

  • AusPAR: Ulipristal acetate

    Australian public assessment report (AusPar)
    Australian public assessment report for Ulipristal acetate

  • AusPAR: Insulin glargine

    Australian public assessment report (AusPar)
    Australian public assessment report for Insulin glargine

  • AusPAR: Trastuzumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Trastuzumab

  • AusPAR: Tafluprost/Timolol

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Tafluprost/Timolol

  • AusPAR: Omalizumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Omalizumab (rch)

  • AusPAR: Dulaglutide rch

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dulaglutide rch

  • AusPAR: Aflibercept

    Australian public assessment report (AusPar)
    Australian public assessment report for Aflibercept

  • AusPAR: Idelalisib

    Australian public assessment report (AusPar)
    AusPAR: Idelalisib

  • AusPAR: Ustekinumab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ustekinumab

  • AusPAR: Umeclidinium bromide

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Umeclidinium bromide

  • AusPAR: Gadobutrol

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Gadobutrol

  • AusPAR: Ponatinib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Ponatinib

  • AusPAR: Suvorexant

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Suvorexant